Krensavage Partners Having Strong 2018 Led By Contrarian Long

According to its third-quarter letter to investors, a copy of which has been reviewed by ValueWalk, Krensavage Partners is having an exceptionally strong 2018. The health-care focused hedge fund managed by Michael Krensavage, was up 18.9% for the year to the end of September, compared to 10.6% for the S&P 500 and 16.6% for the S&P Healthcare Index. Q3 hedge fund letters, conference, scoops etc If you’re looking for more timely hedge fund insight, ValueWalk’s exclusive newsletter Hidden Value Stocks offers exclusive access to under-the-radar value hedge funds and their ideas. Click here to find out more and signup for a free no-obligation trial today. Sector-leading Over the…